The cyclin dependent kinase inhibitor 2A (CDKN2A, also known as p16 or p19), a tumor suppressor, is essential for regulating the G1 to S phase transition in the cell cycle, controlling cell growth. The gene discussed is CDKN2A; the disease is neoplasm.